J. W. Kugler

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

Charles L. Loprinzi, John A. Laurie, Harry S. Wieand et al. · Journal of Clinical Oncology · 1994 · 379 citations

Medicine, Biostatistics, Oncology +15

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.

Edward T. Creagan, Robert J. Dalton, David L. Ahmann et al. · Journal of Clinical Oncology · 1995 · 251 citations

Medicine, Immunology, Oncology +16

Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy

Delvyn C. Case, R. M. Bukowski, Robert W. Carey et al. · JNCI Journal of the National Cancer Institute · 1993 · 201 citations

Medicine, Hematology, Pharmacology +15

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

Kendrith M. Rowland, Charles L. Loprinzi, Edward G. Shaw et al. · Journal of Clinical Oncology · 1996 · 139 citations

Medicine, Oncology, Pharmacology +8

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.

Charles L. Loprinzi, Richard M. Goldberg, John Q. Su et al. · Journal of Clinical Oncology · 1994 · 114 citations

Medicine, Oncology, Pharmacology +9